» Articles » PMID: 20005572

Short- and Long-term Changes in Gene Expression Mediated by the Activation of TLR9

Overview
Journal Mol Immunol
Date 2009 Dec 17
PMID 20005572
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

CpG DNA binds to Toll-like receptor 9 to stimulate a strong innate immune response. The magnitude, duration and scope of CpG-induced changes in gene expression are incompletely understood despite extensive studies of TLR9 mediated signal transduction pathways. In particular, the prolonged effects of CpG DNA on gene activation have not been investigated despite evidence that a single dose of CpG DNA alters immune reactivity for several weeks. This study used gene expression analysis to monitor changes in mRNA levels for 14 days, and identified the genes, pathways and functional groups triggered in vivo following CpG DNA administration. Two discrete peaks of gene activation (at 3h and 5 days) were observed after CpG injection. Both the behavior and function of genes activated during the second peak differed from those triggered shortly after CpG administration. Initial gene up-regulation corresponded to a period when TLR9 ligation stimulated genes functionally associated with the generation of innate and adaptive immune responses (e.g. the NF-kappaB and B-cell receptor pathways). The second peak reflected processes associated with cell division (e.g. cell cycle and DNA replication and repair). The complex bimodal pattern of gene expression elicited by CpG DNA administration provides novel insights into the long-term effects of TLR9 engagement on genes associated with immunity and cell proliferation.

Citing Articles

All-trans retinoic acid (ATRA) regulates key genes in the RARG-TOP2B pathway and reduces anthracycline-induced cardiotoxicity.

Hasbullah J, Scott E, Bhavsar A, Gunaretnam E, Miao F, Soliman H PLoS One. 2022; 17(11):e0276541.

PMID: 36331922 PMC: 9635745. DOI: 10.1371/journal.pone.0276541.


Nucleic Acid Sensing Pathways in DNA Repair Targeted Cancer Therapy.

Xie B, Luo A Front Cell Dev Biol. 2022; 10:903781.

PMID: 35557952 PMC: 9089908. DOI: 10.3389/fcell.2022.903781.


CpG Adjuvant in Allergen-Specific Immunotherapy: Finding the Sweet Spot for the Induction of Immune Tolerance.

Montamat G, Leonard C, Poli A, Klimek L, Ollert M Front Immunol. 2021; 12:590054.

PMID: 33708195 PMC: 7940844. DOI: 10.3389/fimmu.2021.590054.


A suppressive oligodeoxynucleotide expressing TTAGGG motifs modulates cellular energetics through the mTOR signaling pathway.

Yazar V, Kilic G, Bulut O, Canavar Yildirim T, Yagci F, Aykut G Int Immunol. 2019; 32(1):39-48.

PMID: 31633763 PMC: 7185194. DOI: 10.1093/intimm/dxz059.


MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.

Lee B, Shin N, Lee J, Kang I, Kim J, Lee S Front Immunol. 2018; 9:1078.

PMID: 29892282 PMC: 5985498. DOI: 10.3389/fimmu.2018.01078.


References
1.
Elkins K, Stibitz S, Conover J, Klinman D . Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J Immunol. 1999; 162(4):2291-8. View

2.
Sun S, Zhang X, Tough D, Sprent J . Type I interferon-mediated stimulation of T cells by CpG DNA. J Exp Med. 1998; 188(12):2335-42. PMC: 2212431. DOI: 10.1084/jem.188.12.2335. View

3.
Schmitz F, Mages J, Heit A, Lang R, Wagner H . Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: from expression profiling to a model of TLR signaling. Eur J Immunol. 2004; 34(10):2863-73. DOI: 10.1002/eji.200425228. View

4.
Horner A, Raz E . Immunostimulatory sequence oligodeoxynucleotide-based vaccination and immunomodulation: two unique but complementary strategies for the treatment of allergic diseases. J Allergy Clin Immunol. 2002; 110(5):706-12. DOI: 10.1067/mai.2002.129122. View

5.
Krakauer T . Nuclear factor-kappaB: fine-tuning a central integrator of diverse biologic stimuli. Int Rev Immunol. 2008; 27(5):286-92. DOI: 10.1080/08830180802317957. View